[HTML][HTML] Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients
AN Thakkar, SR Bendkhale, SR Taur, NJ Gogtay… - Neurology …, 2012 - journals.lww.com
Background: Genetic polymorphisms of CYP2C9 can lead to wide inter-individual variations
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
[引用][C] Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients
UM Thatte, SR Bendkhale, NJ Gogtay, SR Taur… - Neurology India, 2012 - cir.nii.ac.jp
Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients
AN Thakkar, SR Bendkhale, SR Taur… - Neurology …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Genetic polymorphisms of CYP2C9 can lead to wide inter-individual variations
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients
A Thakkar, S Bendkhale, S Taur, N Gogtay… - Neurology …, 2012 - search.proquest.com
Background: Genetic polymorphisms of CYP2C9 can lead to wide inter-individual variations
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients
A Thakkar, S Bendkhale, S Taur, N Gogtay, U Thatte - Neurology India, 2012 - go.gale.com
Background: Genetic polymorphisms of CYP2C9 can lead to wide inter-individual variations
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
[PDF][PDF] Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients
AN Thakkar, SR Bendkhale, SR Taur, NJ Gogtay… - Neurology …, 2012 - cyberleninka.org
Background: Genetic polymorphisms of CYP2C9 can lead to wide inter‑individual variations
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients.
AN Thakkar, SR Bendkhale, SR Taur, NJ Gogtay… - Neurology …, 2012 - europepmc.org
Background Genetic polymorphisms of CYP2C9 can lead to wide inter-individual variations
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients.
AN Thakkar, SR Bendkhale, SR Taur, NJ Gogtay… - 2012 - cabidigitallibrary.org
Background: Genetic polymorphisms of CYP2C9 can lead to wide inter-individual variations
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients.
AN Thakkar, SR Bendkhale, SR Taur… - Neurology …, 2012 - search.ebscohost.com
Background: Genetic polymorphisms of CYP2C9 can lead to wide inter-individual variations
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …
in drug metabolism. Decreased metabolism leads to higher plasma levels, causing adverse …